By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed (OMED) Presents Initial First-In-Human Data For Anti-DLL4/VEGF Bispecific And Anti-RSPO3 At The 28th EORTC-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium 11/29/2016 8:01:42 AM
OncoMed (OMED) Reports Third Quarter 2016 Financial Results 11/2/2016 8:13:44 AM
OncoMed (OMED) To Report Financial Results For The Third Quarter On Tuesday, November 1, 2016 10/26/2016 8:13:45 AM
OncoMed (OMED) Presents Interim Phase Ib Data For Ipafricept And Vantictumab In Pancreatic Cancer At The ESMO 2016 Congress 10/10/2016 8:45:24 AM
OncoMed (OMED) To Present Clinical Data For Wnt Inhibitors At The ESMO 2016 Congress 9/29/2016 11:32:00 AM
OncoMed (OMED) Management To Present At Two Upcoming Investment Conferences 9/1/2016 8:34:29 AM
OncoMed (OMED) Completes Enrollment Of Phase II YOSEMITE Clinical Trial Of Demcizumab In Pancreatic Cancer 9/1/2016 8:32:59 AM
OncoMed (OMED) Completes Enrollment Of Phase II PINNACLE Clinical Trial Of Tarextumab In Small Cell Lung Cancer 8/30/2016 7:51:15 AM
OncoMed (OMED) Announces Closing Of Public Offering Including Exercise Of Underwriters' Right To Purchase Additional Shares 8/24/2016 8:07:41 AM
OncoMed (OMED) Announces Pricing Of Public Offering Of Common Stock 8/18/2016 8:01:17 AM
12345678910...
//-->